info@athenex.com
716.427.2950
Athenex
Improving the lives of cancer patients everywhere
About
About Athenex
Our Other Companies
Our Partnerships
Oncology Innovation
Orascovery Platform
Src Kinase Inhibition
Dual Inhibition
TCR-T Immunotherapy
Pegylated Genetically Modified Human Arginase
Clinical Trials
Operating Platforms
Commercial Segment
Internal Supply Chain
Our Team
Our Board of Directors
Our Leadership Team
Other Key Employees
Our Advisors
Careers
Investor Relations
Overview
Stock Information
Stock Quote & Chart
Historical Price Lookup
Investment Calculator
Analyst Coverage
News & Events
Press Releases
Events & Presentations
Financial Information
SEC Filings
Annual Meeting Materials
Annual Reports
Quarterly Results
Corporate Governance
Governance Highlights
Committee Composition
Investor Resources
Investor FAQs
Information Request
E-mail Alerts
IR Contacts
Menu
back
Event Details
Q1 2018 Athenex, Inc. Earnings Conference Call
Monday, May 14, 2018 9:00 a.m. ET
Webcast Presentation
Click here for webcast
Event Details
Title
Q1 2018 Athenex, Inc. Earnings Conference Call
Date / Time
May 14, 2018 9:00 a.m. ET
Print Page
E-mail Page
RSS
E-mail Alerts
Tearsheet
Overview
Stock Information
Stock Quote & Chart
Historical Price Lookup
Investment Calculator
Analyst Coverage
News & Events
Press Releases
Events & Presentations
Financial Information
SEC Filings
Annual Meeting Materials
Annual Reports
Quarterly Results
Corporate Governance
Governance Highlights
Committee Composition
Investor Resources
Investor FAQs
Information Request
E-mail Alerts
IR Contacts
Learn More
